Drug Shortage Report for SANDOZ PANTOPRAZOLE
Report ID | 44760 |
Drug Identification Number | 02301075 |
Brand name | SANDOZ PANTOPRAZOLE |
Common or Proper name | PANTOPRAZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PANTOPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 TABLETS |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-03-23 |
Actual start date | 2018-03-27 |
Estimated end date | 2018-06-01 |
Actual end date | 2018-05-30 |
Shortage status | Resolved |
Updated date | 2018-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-05-31 | French | Compare |
v7 | 2018-05-31 | English | Compare |
v6 | 2018-05-23 | French | Compare |
v5 | 2018-05-23 | English | Compare |
v4 | 2018-04-13 | French | Compare |
v3 | 2018-04-13 | English | Compare |
v2 | 2018-04-03 | French | Compare |
v1 | 2018-04-03 | English | Compare |
Showing 1 to 8 of 8